glimepiride has been researched along with tak-875 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, CJ | 1 |
| Burant, CF; Cao, C; Leifke, E; Marcinak, J; Vakilynejad, M; Viswanathan, P; Xie, B | 1 |
| Ito, R; Matsuda, K; Miyawaki, K; Suzuki, M; Takeuchi, K; Tsujihata, Y | 1 |
| Marcinak, JF; Munsaka, MS; Ohira, T; Smith, N; Watkins, PB | 1 |
2 trial(s) available for glimepiride and tak-875
| Article | Year |
|---|---|
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzofurans; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Maximum Tolerated Dose; Middle Aged; Risk Assessment; Sulfones; Sulfonylurea Compounds; Treatment Outcome | 2012 |
Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
Topics: Adult; Aged; Alanine Transaminase; Benzofurans; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Liver; Male; Middle Aged; Sitagliptin Phosphate; Sulfones; Sulfonylurea Compounds | 2018 |
2 other study(ies) available for glimepiride and tak-875
| Article | Year |
|---|---|
Could FFAR1 assist insulin secretion in type 2 diabetes?
Topics: Benzofurans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Sulfones; Sulfonylurea Compounds | 2012 |
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
Topics: Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Glucose Tolerance Test; Glyburide; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; Sulfones; Sulfonylurea Compounds | 2016 |